Cargando…

Physician requests by patients with malignant pleural mesothelioma in Japan

BACKGROUND: Malignant pleural mesothelioma (MPM) is a fatal and rare disease that is caused by the inhalation of asbestos. Treatment and care requests made by MPM patients to their physicians were collected and analyzed. METHODS: This cross-sectional survey was part of a larger study (N = 133) regar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagamatsu, Yasuko, Oze, Isao, Aoe, Keisuke, Hotta, Katsuyuki, Kato, Katsuya, Nakagawa, Junko, Hara, Keiko, Kishimoto, Takumi, Fujimoto, Nobukazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485076/ https://www.ncbi.nlm.nih.gov/pubmed/31023248 http://dx.doi.org/10.1186/s12885-019-5591-7

Ejemplares similares

Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study
por: Nagamatsu, Yasuko, et al.
Publicado: (2018)

Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma
por: Fujimoto, Nobukazu, et al.
Publicado: (2014)

Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
por: Hotta, Katsuyuki, et al.
Publicado: (2020)

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
por: Miyamoto, Yosuke, et al.
Publicado: (2021)

Foreign body granuloma mimicking recurrence of malignant pleural mesothelioma
por: Nakasuka, Takamasa, et al.
Publicado: (2015)

Clinical Investigation of Benign Asbestos Pleural Effusion
por: Fujimoto, Nobukazu, et al.
Publicado: (2015)

Phrenic Nerve Paralysis as the Initial Presentation in Pleural Sarcomatoid Mesothelioma
por: Makimoto, Go, et al.
Publicado: (2014)

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma
por: Nakagawa, Kazuhiko, et al.
Publicado: (2021)

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study
por: Fujimoto, Nobukazu, et al.
Publicado: (2020)

An appropriate choice for immunotherapy in malignant pleural mesothelioma
por: Fujimoto, Nobukazu
Publicado: (2020)

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma
por: AMATYA, VISHWA JEET, et al.
Publicado: (2012)

Spare the lung: surgical treatment approach for malignant pleural mesothelioma
por: Fujimoto, Nobukazu
Publicado: (2023)

Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion
por: Kishimoto, Takumi, et al.
Publicado: (2021)

Lymphoproliferative disorder in pleural effusion in a subject with past asbestos exposure
por: Hara, Naofumi, et al.
Publicado: (2015)

Depression and Complicated Grief, and Associated Factors, of Bereaved Family Members of Patients Who Died of Malignant Pleural Mesothelioma in Japan
por: Nagamatsu, Yasuko, et al.
Publicado: (2022)

Bilateral Pleural Effusions as an Initial Presentation in Primary Sjögren's Syndrome
por: Makimoto, Go, et al.
Publicado: (2012)

Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report
por: Tanaka, Takaaki, et al.
Publicado: (2022)

Retrospective investigation on diagnostic process for benign asbestos pleural effusion (BAPE) using checklist
por: Kishimoto, Takumi, et al.
Publicado: (2020)

Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients
por: Kishimoto, Takumi, et al.
Publicado: (2019)

Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma
por: Yamamoto, J, et al.
Publicado: (2014)

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
por: Sato, Hiroki, et al.
Publicado: (2018)

A patient with epithelioid pleural mesothelioma (Myxoid variant) who survived for a long period without treatment
por: Mizuhashi, Keiichi, et al.
Publicado: (2021)

Bereaved Family Members’ Perspectives of Good Death and Quality of End-of-Life Care for Malignant Pleural Mesothelioma Patients: A Cross-Sectional Study
por: Nagamatsu, Yasuko, et al.
Publicado: (2022)

Survey of malignant pleural mesothelioma treatment in Japan: Patterns of practice and clinical outcomes in tomotherapy facilities
por: Nakanishi-Imai, Mikiko, et al.
Publicado: (2022)

Functional Properties of CD8(+) Lymphocytes in Patients with Pleural Plaque and Malignant Mesothelioma
por: Kumagai-Takei, Naoko, et al.
Publicado: (2014)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Pleural effusion related to IgG4
por: Murata, Yoriyuki, et al.
Publicado: (2019)

Endobronchial T-cell lymphoma in a patient with chronic pyothorax
por: Matsumoto, Shinsaku, et al.
Publicado: (2015)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Pleural Mesothelioma in the Era of Immunotherapy
por: Chevallier, Mathieu, et al.
Publicado: (2023)

A retrospective study on radiological findings of diffuse pleural thickening with benign asbestos pleural effusion in Japanese cases
por: KISHIMOTO, Takumi, et al.
Publicado: (2021)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_50gi8c80h672djrbv48sa89d75